• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期症状/临床发现的可靠性 颌骨骨坏死:日本骨质疏松症干预试验-05(JOINT-05)。

Reliability of early stage symptoms/clinical findings of osteonecrosis of the jaw: Japanese Osteoporosis Intervention Trial-05 (JOINT-05).

机构信息

Department of Oral and Maxillofacial Radiology, School of Dentistry, Matsumoto Dental University, 1780 Hirooka Gobara, Shiojiri, Nagano, 399-0781, Japan.

Department of Hard Tissue Research, Graduate School of Oral Medicine, Matsumoto Dental University, 1780 Gobara, Hirooka, Shiojiri, Nagano, 399-0781, Japan.

出版信息

J Bone Miner Metab. 2023 Nov;41(6):854-864. doi: 10.1007/s00774-023-01466-3. Epub 2023 Oct 28.

DOI:10.1007/s00774-023-01466-3
PMID:37897672
Abstract

INTRODUCTION

To investigate the differences in the incidence rates of suspected stage 0/1 osteonecrosis of the jaw (ONJ) and incidence risk of relevant clinical findings of suspected stage 0 ONJ between patients treated with sequential therapy comprising weekly teriparatide for 72 weeks followed by alendronate for 48 weeks vs. those who received monotherapy with alendronate for 120 weeks.

MATERIALS AND METHODS

Suspected stage 0/1 ONJ was defined by non-specific symptoms. Tooth mobility and periodontal symptoms (gingival bleeding, swelling, and/or pain) were selected as clinical findings of suspected stage 0 ONJ. Poisson regression models were applied to calculate the incidence rate ratios of suspected stage 0/1 between the teriparatide group (TG) and alendronate group (AG). Generalized linear models were used to calculate the risk ratios of clinical findings between groups.

RESULTS

Two hundred and sixty-one participants in the TG and 344 in the AG answered a structured questionnaire on oral health and were included in this study. There were no significant differences between the groups in the incidence rate of suspected stage 0/1 ONJ at both 72 and 120 weeks. The risk ratio of the TG to AG for tooth mobility was 0.34 (95% confidence interval [CI] 0.13-0.88, p = 0.02) at 72 weeks and 0.90 (95% CI 0.40-2.03, p = 0.83) at 120 weeks. The incidence rate of tooth mobility related to periodontal symptoms decreased in the TG and increased in the AG during the study.

CONCLUSION

Tooth mobility accompanied by clinical periodontal symptoms may be a useful early sign of stage 0 ONJ.

摘要

介绍

研究每周特立帕肽治疗 72 周序贯治疗与 120 周阿仑膦酸钠单药治疗相比,0/1 期疑似颌骨骨坏死(ONJ)发生率及疑似 0 期 ONJ 相关临床发现的发生率差异。

材料和方法

疑似 0/1 期 ONJ 通过非特异性症状定义。牙齿松动和牙周症状(牙龈出血、肿胀和/或疼痛)被选为疑似 0 期 ONJ 的临床发现。应用泊松回归模型计算特立帕肽组(TG)和阿仑膦酸钠组(AG)疑似 0/1 期的发病率比值。采用广义线性模型计算组间临床发现的风险比。

结果

261 名 TG 患者和 344 名 AG 患者回答了一份关于口腔健康的结构化问卷,并纳入本研究。在 72 周和 120 周时,两组疑似 0/1 期 ONJ 的发生率均无显著差异。72 周时,TG 组至 AG 组牙齿松动的风险比为 0.34(95%置信区间[CI] 0.13-0.88,p=0.02),120 周时为 0.90(95% CI 0.40-2.03,p=0.83)。在研究期间,TG 组牙齿松动与牙周症状相关的发生率下降,AG 组增加。

结论

伴有临床牙周症状的牙齿松动可能是 0 期 ONJ 的一个有用的早期征象。

相似文献

1
Reliability of early stage symptoms/clinical findings of osteonecrosis of the jaw: Japanese Osteoporosis Intervention Trial-05 (JOINT-05).早期症状/临床发现的可靠性 颌骨骨坏死:日本骨质疏松症干预试验-05(JOINT-05)。
J Bone Miner Metab. 2023 Nov;41(6):854-864. doi: 10.1007/s00774-023-01466-3. Epub 2023 Oct 28.
2
Incidence and risk of osteonecrosis of the jaw among the Taiwan osteoporosis population.台湾骨质疏松症人群中颌骨坏死的发病率及风险
Osteoporos Int. 2014 May;25(5):1503-11. doi: 10.1007/s00198-014-2624-6. Epub 2014 Feb 11.
3
Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report.双膦酸盐相关颌骨坏死,经特立帕肽治疗后愈合:文献综述及病例报告
Spec Care Dentist. 2010 Mar-Apr;30(2):77-82. doi: 10.1111/j.1754-4505.2009.00128.x.
4
Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users.接受阿仑膦酸钠治疗的高度依从性患者的颌骨和口腔外科治疗的骨坏死和骨髓炎:一项包括超过 60000 名阿仑膦酸钠使用者的全国性仅限使用者队列研究。
Osteoporos Int. 2017 Oct;28(10):2921-2928. doi: 10.1007/s00198-017-4132-y. Epub 2017 Jun 29.
5
Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05.每周一次特立帕肽注射序贯治疗联合阿仑膦酸钠与单独使用阿仑膦酸钠治疗骨质疏松性骨折高风险患者的比较:日本骨质疏松干预试验-05 的最终结果。
Osteoporos Int. 2023 Jan;34(1):189-199. doi: 10.1007/s00198-022-06570-0. Epub 2022 Oct 14.
6
Incidence of osteonecrosis of the jaw in Japanese osteoporosis patients taking minodronic acid.接受米诺膦酸治疗的日本骨质疏松症患者颌骨坏死的发生率。
J Bone Miner Metab. 2019 Sep;37(5):886-892. doi: 10.1007/s00774-019-00990-5. Epub 2019 Feb 4.
7
The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects.阿仑膦酸盐和拔牙对骨质疏松患者颌骨坏死发生率的影响。
PLoS One. 2018 Apr 25;13(4):e0196419. doi: 10.1371/journal.pone.0196419. eCollection 2018.
8
Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ.基于病例的颌骨骨坏死(ONJ)回顾及国际ONJ特别工作组国际管理建议的应用
J Clin Densitom. 2017 Jan-Mar;20(1):8-24. doi: 10.1016/j.jocd.2016.09.005. Epub 2016 Dec 9.
9
The risk of osteonecrosis of the jaws in Taiwanese osteoporotic patients treated with oral alendronate or raloxifene.台湾地区接受口服阿仑膦酸盐或雷洛昔芬治疗的骨质疏松症患者发生颌骨坏死的风险。
J Clin Endocrinol Metab. 2014 Aug;99(8):2729-35. doi: 10.1210/jc.2013-4119. Epub 2014 Apr 23.
10
Incidence of and risk for osteonecrosis of the jaw in Korean osteoporosis patients treated with bisphosphonates: A nationwide cohort-study.接受双磷酸盐治疗的韩国骨质疏松症患者颌骨坏死的发生率和风险:一项全国性队列研究。
Bone. 2021 Feb;143:115650. doi: 10.1016/j.bone.2020.115650. Epub 2020 Sep 19.

引用本文的文献

1
A Study on the Prevalence of Osteoporosis in People with Different Altitudes in Sichuan, China.中国四川不同海拔人群骨质疏松症患病率研究。
Clin Interv Aging. 2024 Nov 5;19:1819-1828. doi: 10.2147/CIA.S478020. eCollection 2024.

本文引用的文献

1
Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan.日本吴市 2016 年至 2020 年抗吸收剂相关性颌骨坏死的发病率和趋势。
Osteoporos Int. 2023 Jun;34(6):1101-1109. doi: 10.1007/s00198-023-06732-8. Epub 2023 Mar 31.
2
Interventions for managing medication-related osteonecrosis of the jaw.干预措施管理与药物相关的颌骨坏死。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD012432. doi: 10.1002/14651858.CD012432.pub3.
3
American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update.
美国口腔颌面外科学会关于药物相关性颌骨坏死的立场文件-2022 更新。
J Oral Maxillofac Surg. 2022 May;80(5):920-943. doi: 10.1016/j.joms.2022.02.008. Epub 2022 Feb 21.
4
Prevalence of Periapical Lesions in Patients with Osteoporosis.骨质疏松症患者根尖周病变的患病率。
J Endod. 2021 Feb;47(2):234-238. doi: 10.1016/j.joen.2020.10.019. Epub 2020 Oct 29.
5
Associations between osteoporosis and risk of periodontitis: A pooled analysis of observational studies.骨质疏松症与牙周炎风险的关联:观察性研究的汇总分析。
Oral Dis. 2021 Mar;27(2):357-369. doi: 10.1111/odi.13531. Epub 2020 Nov 21.
6
Fragility fractures and delayed wound healing after tooth extraction in Japanese older adults.日本老年人拔牙后的脆性骨折和延迟伤口愈合。
J Bone Miner Metab. 2020 May;38(3):357-362. doi: 10.1007/s00774-019-01063-3. Epub 2020 Jan 2.
7
Design of a randomized trial of teriparatide followed by alendronate: Japanese Osteoporosis Intervention Trial-05 (JOINT-05).特立帕肽序贯阿仑膦酸钠的随机临床试验设计:日本骨质疏松干预试验-05(JOINT-05)。
J Bone Miner Metab. 2020 May;38(3):412-417. doi: 10.1007/s00774-019-01074-0. Epub 2020 Jan 1.
8
A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration.特立帕肽治疗药物相关性颌骨坏死的疗效比较研究:每日与每周给药。
Osteoporos Int. 2020 Mar;31(3):577-585. doi: 10.1007/s00198-019-05199-w. Epub 2019 Nov 25.
9
Improved periodontal disease and prevention of tooth loss in osteoporosis patients receiving once-yearly zoledronic acid: a randomized clinical trial.接受唑来膦酸每年一次治疗的骨质疏松症患者中牙周病的改善和牙齿脱落的预防:一项随机临床试验。
Menopause. 2019 Nov;26(11):1277-1283. doi: 10.1097/GME.0000000000001393.
10
Effects of Bone Fragility and Antiresorptive Drugs on Periodontal Disease and Tooth Loss: A Longitudinal Study.骨脆性和抗吸收药物对牙周疾病及牙齿脱落的影响:一项纵向研究
JDR Clin Trans Res. 2018 Oct;3(4):378-387. doi: 10.1177/2380084418787451. Epub 2018 Jul 9.